Microbiome of Donor Iron Deficient Study

Sponsor
Columbia University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02990988
Collaborator
(none)
70
1
65
1.1

Study Details

Study Description

Brief Summary

The goal of this pilot study is to test whether the microbiome is affected by intravenous iron repletion.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The colonic microbiome, the community of bacteria living in our gut, is essential in human health and disease. Iron is an essential nutrient for both bacteria and humans. In the United States, of the donors who provided the ~15 million units of red blood cells that were collected for transfusion, 69% were repeat donors. Although iron deficiency is surprisingly prevalent in first-time donors, its prevalence is even higher in these particularly altruistic frequent donors, (i.e., up to 49% and 66% of male and female repeat donors, respectively), manifested as iron depletion or iron-deficient erythropoiesis. Iron deficiency from blood donation is associated with fatigue, restless leg syndrome, decreased physical endurance and work capacity, and impaired concentration, attention, and other neurocognitive functions; however, these conclusions are not based on definitive studies and have not yet changed blood donation policy. The goal is to conduct a prospective, double-blind, randomized controlled trial, recruiting 60 healthy regular donors who meet donation standards, while exhibiting iron-deficient erythropoiesis by laboratory test criteria. In this ancillary study, we will determine what effect donor iron deficiency and IV iron repletion have on the gut microbiome.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    70 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Microbiome of Donor Iron Deficient Study (DIDS)
    Study Start Date :
    Jan 1, 2017
    Anticipated Primary Completion Date :
    Jun 1, 2022
    Anticipated Study Completion Date :
    Jun 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Iron repletion

    Subjects participating in the associated study under the Iron Repletion arm will also provide stool collection and answers to questionnaire and diet diary.

    Placebo

    Subjects participating in the associated study under the Placebo arm will also provide stool collection and answers to questionnaire and diet diary.

    Outcome Measures

    Primary Outcome Measures

    1. Change in overall diversity of fecal flora [Baseline, 5-days, 4-weeks, 5 months]

      Stool samples will be collected and processed.

    2. Change in fecal indoles [Baseline, 5-days, 4-weeks, 5 months]

      Indole concentrations measured in fecal samples

    3. Change in fecal iron [Baseline, 5-days, 4-weeks, 5 months]

      Iron concentrations measured in fecal samples

    Secondary Outcome Measures

    1. Mean Bray-Curtis indices [Baseline, 5-days, 4-weeks, 5 months]

      Calculation of Bray-Curtis index will determine the relative abundance of specific taxa (e.g., Firmicutes, Bacteroidetes, Proteobacteria) for each subject. Means (of the differences in %) and standard deviations will be calculated for all comparisons, and a multivariable generalized estimating equations (GEE) model will be used to test for significance.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Current participant of the associated randomized controlled trial conducted at Columbia University Medical Center (therefore invited to participate in this optional ancillary study).
    Exclusion Criteria:
    • Not a current participant of the associated randomized controlled trial conducted at Columbia University Medical Center.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Columbia University Medical Center New York New York United States 10023

    Sponsors and Collaborators

    • Columbia University

    Investigators

    • Principal Investigator: Eldad Hod, MD, Associate Professor of Pathology and Cell Biology, Dept of Pathology&Cell Biology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Columbia University
    ClinicalTrials.gov Identifier:
    NCT02990988
    Other Study ID Numbers:
    • AAAR1265
    First Posted:
    Dec 13, 2016
    Last Update Posted:
    Dec 29, 2021
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Columbia University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 29, 2021